[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"LungenClinic Grosshansdorf\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":80},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,47],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":24,"studyType":25,"phases":4,"briefSummary":26,"conditions":27,"keywords":29,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100241287","adult-arm-of-dzl-all-age-asthma-cohort-alliance-100241287",false,"NCT02419274","Adult Arm of DZL All Age Asthma Cohort (ALLIANCE)","The All Age Asthma Cohort (ALLIANCE) of the German Center for Lung Research (DZL), Adult Arm","ALLIANCE","Inclusion Criteria:\n\n* Proven Diagnosis according to current GINA Guideline (2014)\n* Ability to read and understand German\n* Ability to understand and agree to informed consent\n\nExclusion Criteria:\n\n* History of respiratory tract infection within the last 4 weeks before inclusion",true,"ALL","18 Years","99 Years",{"count":22,"type":23},400,"ESTIMATED","6 Years","OBSERVATIONAL","Deep Phenotyping of adult asthma patients:\n\n* severity from mild to severe\n* both atopic and non-atopic\n* both childhood and adult onset\n* both smokers and non-smokers\n* corresponding pediatric cohort (Pediatric Arm of DZL All Age Asthma Cohort) with equivalent SOPs regarding collection of biomaterial and clinical data incl. lung function, further processing of biomaterial and further analyses",[28],"Asthma",[30,31,32,33],"asthma","phenotype","childhood","adulthood","RECRUITING","2023-10-11",{"date":37,"type":38},"2023-10-12","ACTUAL",{"date":40,"type":4},"2014-03",{"date":42,"type":23},"2030-12",{"name":44,"class":45},"LungenClinic Grosshansdorf","OTHER",1,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":55,"targetDuration":4,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":64,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":46},"100491258","hsi-for-intersegmental-plane-identification-during-sublobar-pulmonary-resections-100491258","NCT05676788","HSI for Intersegmental Plane Identification During Sublobar Pulmonary Resections","Hyperspectral Imaging for Intersegmental Plane Identification During Sublobar Pulmonary Resections in Lung Cancer Patients","HYPER-Seg","Inclusion Criteria:\n\n1. Histologically confirmed lung cancer stage I\u002FII or malignancy suspicious nodules\n2. Segmentectomy is oncologically indicated or impaired pulmonary and\u002For cardiac function prevent anatomical resection\n3. Male or female patients aged ≥ 18 years without upper age limit\n4. Serum creatinine ≤ 1.5 x upper limit of normal or creatinine clearance (CrCl ≥ 50 mL\u002Fmin, Cockcroft-Gault formula)\n5. Total bilirubin ≤ 1.5 x upper limit of normal (except patients with Gilbert Syndrome (Morbus Meulengracht) in whom total bilirubin \\\u003C 3.0 mg\u002FdL is allowed)\n6. Aspartate aminotransferase (AST) (serum glutamic-oxaloacetic transaminase)\u002Falanine aminotransferase (ALT) (serum glutamate pyruvate transaminase) ≤ 2.5 x upper limit of normal\n7. Full legal capacity\n8. Written informed consent obtained according to international guidelines and local laws\n9. Ability to understand the nature of the trial and the trial related procedures and to comply with them\n\nExclusion Criteria:\n\n1. Requirement of a lobectomy or pneumonectomy to achieve complete resection\n2. Allergy to indocyanine green or iodine\n3. Hyperthyroidism\n4. Current or planned pregnancy, nursing period (if defined as requirement of clinical routine treatment)\n5. Medical condition which poses a high risk to undergo surgery as defined by the investigator\n6. Covid19 \u002F SARS-CoV2-infection at time of screening\n7. Participation in any other interventional clinical trial within the last 30 days before the start of this trial\n8. Simultaneous participation in other interventional trials which could interfere with this trial; simultaneous participation in registry and diagnostic trials is allowed\n9. Known or persistent abuse of medication, drugs or alcohol\n10. Person who is in a relationship of dependence\u002Femployment with the coordinating investigator or the investigator",{"count":56,"type":23},50,"INTERVENTIONAL",[59],"NA","The purpose of this study is the identification of the intersegmental plane and navigation during sublobar pulmonary resections in lung cancer using Hyperspectral Imaging, the comparison with ICG fluorescence intersegmental plane identification, and the establishment of automatic intersegmental plane navigation using machine learning strategies for intraoperative navigation.",[62,63],"Lung Neoplasm","Pulmonary Metastasis",[65,66,67,68,69,70],"Hyperspectral Imaging","Lung cancer","Segmentectomy","Indocyanine green","Intersegmental plane","Machine learning strategies","NOT_YET_RECRUITING","2023-01-06",{"date":74,"type":38},"2023-01-09",{"date":76,"type":23},"2023-04",{"date":78,"type":23},"2027-06",{"name":44,"class":45},""]